Incyte Corp (LTS:0J9P)
$ 77.12 0.9112 (1.2%) Market Cap: 14.89 Bil Enterprise Value: 13.15 Bil PE Ratio: 541.07 PB Ratio: 4.61 GF Score: 90/100

Incyte Corp at BMO Capital Markets Biopharma Spotlight Series: Oncology (Virtual) Transcript

Nov 08, 2021 / 09:10PM GMT
Release Date Price: $66.67 (-2.01%)
Evan Seigerman

All right. We made it to the final session of our Oncology Summit. And last and certainly not least is Incyte. So from Incyte, we have a full house, but I'll introduce Herve Hoppenot, Chairman, President and CEO; Steven Stein, Chief Medical Officer; and Christiana Stamoulis, CFO; and of course, the fabulous IR team. Thank you guys for joining me. I really like this setup. It's nice to have everyone on one panel.

Before we jump in, I just want to address a few housekeeping items, and then we can go into Q&A. On the Webex, if you'd like to ask a question, there is a mechanism to do so. You can also e-mail me, [email protected], and I'm happy to ask on your behalf.

And thank you, everyone, for joining us. We were just talking before the session started about how we want to do this in person next time, how -- too many months of Zoom and Webex calls at this point. But thank you, guys, for joining. We're glad you're here. So Herve, before we...

Herve Hoppenot
Incyte Corporation - Chairman, President & CEO

No, thank you for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot